Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Changing epidemiology of immune-mediated inflammatory diseases in immigrants: A systematic review of population-based studies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. GPR15+ T cells are Th17 like, increased in smokers and associated with multiple sclerosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Nutritional recommendations for gout: An update from clinical epidemiology

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Lupus nephritis and pregnancy outcome

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Helena Enocsson
  • Lina Wirestam
  • Charlotte Dahle
  • Leonid Padyukov
  • Andreas Jönsen
  • Murray B Urowitz
  • Dafna D Gladman
  • Juanita Romero-Diaz
  • Sang-Cheol Bae
  • Paul R Fortin
  • Jorge Sanchez-Guerrero
  • Ann E Clarke
  • Sasha Bernatsky
  • Caroline Gordon
  • John G Hanly
  • Daniel J Wallace
  • David A Isenberg
  • Anisur Rahman
  • Joan T Merrill
  • Ellen Ginzler
  • Graciela S Alarcón
  • W Winn Chatham
  • Michelle Petri
  • Munther Khamashta
  • Cynthia Aranow
  • Meggan Mackay
  • Mary Anne Dooley
  • Susan Manzi
  • Rosalind Ramsey-Goldman
  • Ola Nived
  • Kristjan Steinsson
  • Asad A Zoma
  • Guillermo Ruiz-Irastorza
  • S Sam Lim
  • Kenneth C Kalunian
  • Murat Inanc
  • Ronald F van Vollenhoven
  • Manuel Ramos-Casals
  • Diane L Kamen
  • Søren Jacobsen
  • Christine A Peschken
  • Anca Askanase
  • Thomas Stoll
  • Ian N Bruce
  • Jonas Wetterö
  • Christopher Sjöwall
Vis graf over relationer

OBJECTIVE: The soluble urokinase plasminogen activator receptor (suPAR) has potential as a prognosis and severity biomarker in several inflammatory and infectious diseases. In a previous cross-sectional study, suPAR levels were shown to reflect damage accrual in cases of systemic lupus erythematosus (SLE). Herein, we evaluated suPAR as a predictor of future organ damage in recent-onset SLE.

METHODS: Included were 344 patients from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort who met the 1997 American College of Rheumatology classification criteria with 5-years of follow-up data available. Baseline sera from patients and age- and sex-matched controls were assayed for suPAR. Organ damage was assessed annually using the SLICC/ACR damage index (SDI).

RESULTS: The levels of suPAR were higher in patients who accrued damage, particularly those with SDI≥2 at 5 years (N = 32, 46.8% increase, p = 0.004), as compared to patients without damage. Logistic regression analysis revealed a significant impact of suPAR on SDI outcome (SDI≥2; OR = 1.14; 95% CI 1.03-1.26), also after adjustment for confounding factors. In an optimized logistic regression to predict damage, suPAR persisted as a predictor, together with baseline disease activity (SLEDAI-2K), age, and non-Caucasian ethnicity (model AUC = 0.77). Dissecting SDI into organ systems revealed higher suPAR levels in patients who developed musculoskeletal damage (SDI≥1; p = 0.007).

CONCLUSION: Prognostic biomarkers identify patients who are at risk of acquiring early damage and therefore need careful observation and targeted treatment strategies. Overall, suPAR constitutes an interesting biomarker for patient stratification and for identifying SLE patients who are at risk of acquiring organ damage during the first 5 years of disease.

OriginalsprogEngelsk
TidsskriftJournal of Autoimmunity
Vol/bind106
Sider (fra-til)102340
ISSN0896-8411
DOI
StatusUdgivet - jan. 2020

Bibliografisk note

Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

ID: 58900323